- Trials with a EudraCT protocol (802)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (7)
802 result(s) found for: Chronic hepatitis.
Displaying page 1 of 41.
EudraCT Number: 2011-004394-90 | Sponsor Protocol Number: IM1 | Start Date*: 2012-01-05 | ||||||||||||||||
Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Gastroenterologie und Hepatologie | ||||||||||||||||||
Full Title: Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - IM1 | ||||||||||||||||||
Medical condition: Patients with CHC and liver cirrhosis who are not applicable to standard therapy due to the presence of a contraindication. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-006588-21 | Sponsor Protocol Number: HLS02/2006 | Start Date*: 2007-05-10 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: Fluvastatin as adjuvant therapy to alfa-interferon and ribavirin in the treatment of chronic hepatitis C in patients with HIV-1 coinfection | |||||||||||||
Medical condition: Chronic hepatitis C in HIV/HCV coinfection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000279-40 | Sponsor Protocol Number: SF3PEG-RIBA | Start Date*: 2007-02-15 | |||||||||||
Sponsor Name:A.S.L. 2 | |||||||||||||
Full Title: Randomised phase 3B study on comparison of 2 treatment schedules with peginterferon alpha 2b and ribavirin short term versus standard term schedules in patients with chronic hepatitis C, genotype... | |||||||||||||
Medical condition: Patients with chronic hepatitis C with genotype 2 or 3 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005370-49 | Sponsor Protocol Number: ML20601 | Start Date*: 2006-12-13 | |||||||||||
Sponsor Name:Roche Latvia | |||||||||||||
Full Title: Baltic Post-marketing Program of PEGASYS® (Peg interferon alpha-2a 40KD) in Patients with HBeAg-positive Chronic Hepatitis B | |||||||||||||
Medical condition: HBeAg positive chronic Hepatitis B virus (ICD classification code: B18) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) LT (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002069-77 | Sponsor Protocol Number: RG101-05 | Start Date*: 2016-12-01 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Regulus Therapeutics Inc. | ||||||||||||||||||||||||||||||||||||||
Full Title: An Observational Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Have Previously Received RG-101 | ||||||||||||||||||||||||||||||||||||||
Medical condition: Hepatitis C Patients | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: GR (Completed) HU (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001942-16 | Sponsor Protocol Number: GS-US-334-0133 | Start Date*: 2012-08-10 | ||||||||||||||||
Sponsor Name:Gilead Sciences Inc. | ||||||||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Investigate the Efficacy and Safety of GS-7977 + Ribavirin for 12 Weeks in Treatment-Naïve and Treatment-Experienced Su... | ||||||||||||||||||
Medical condition: Chronic Genotype 2 or 3 HCV Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: EE (Completed) AT (Completed) NL (Completed) DE (Completed) GB (Completed) SE (Completed) ES (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-001071-40 | Sponsor Protocol Number: ISM10-06 | Start Date*: 2011-08-11 | ||||||||||||||||
Sponsor Name:InSpira Medical AB | ||||||||||||||||||
Full Title: A Phase IIa Safety study of oral administration of anti-CD3 monoclonal antibody in non-responder genotype-I chronic Hepatitis C subjects, a single-blind, randomized, controlled multi-center study | ||||||||||||||||||
Medical condition: in non-responder genotype-I chronic Hepatitis C subjects | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) PL (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002483-26 | Sponsor Protocol Number: 1998/2005 | Start Date*: 2005-12-01 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Tailoring antiviral therapy of chronic hepatitis C to the single patient standard therapy versus treatment guided by a physic-mathematical model of the dynamics of Hepatitis C Virus infection. | |||||||||||||
Medical condition: Chronic Hepatitis C with or without cirrhosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002069-36 | Sponsor Protocol Number: 5189 | Start Date*: 2013-02-06 | |||||||||||
Sponsor Name:Hôpitaux Universitaires de Strasbourg | |||||||||||||
Full Title: Randomized controlled clinical trial investigating Erlotinib for the treatment of chronic hepatitis C virus infection | |||||||||||||
Medical condition: C hepatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018361-33 | Sponsor Protocol Number: HCV689-201 | Start Date*: 2010-09-10 | ||||||||||||||||||||||||||
Sponsor Name:Arrow Therapeutics Ltd. (a member of the AstraZeneca group of companies) | ||||||||||||||||||||||||||||
Full Title: A Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AZD7295 in Combination with Pegylated Interferon alpha-2a and Ribavirin in P... | ||||||||||||||||||||||||||||
Medical condition: Chronic hepatitis C virus (genotype 1b) infection | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: SK (Completed) HU (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004714-40 | Sponsor Protocol Number: GS-US-203-0101 | Start Date*: 2007-09-17 | |||||||||||
Sponsor Name:Gilead Sciences Incorporated | |||||||||||||
Full Title: A Randomized, Double Blind Study Evaluating Tenofovir Disoproxil Fumarate (DF) Monotherapy Versus the Combination of Emtricitabine and Tenofovir DF for the Treatment of Chronic Hepatitis B | |||||||||||||
Medical condition: Chronic Hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004852-38 | Sponsor Protocol Number: MV 17149 - HELPS | Start Date*: 2005-04-06 | |||||||||||
Sponsor Name:ROCHE | |||||||||||||
Full Title: A randomized, open label, multicenter, parallel group study evaluating the efficacy and safety of 135 mcg and 90 mcg of Pegasys given as monotherapy to patients with chronic hepatitis C and end-sta... | |||||||||||||
Medical condition: chronic hepatitis C CHC virus infection in patients with end-stage renal disease ESRD undergoing hemodialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001927-39 | Sponsor Protocol Number: ST1472-DM-03-007 | Start Date*: 2005-01-20 | |||||||||||
Sponsor Name:SIGMA-TAU | |||||||||||||
Full Title: A PHASE II, MULTICENTER, UNCONTROLLED, OPEN STUDY IN PATIENTS WITH CHRONIC HEPATITIS C WHO ARE INTOLERANT TO INTERFERONS THERAPY TO EVALUATE THE SAFETY AND EFFICACY OF A TREATMENT WITH THYMOSIN ALP... | |||||||||||||
Medical condition: TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C WHO ARE INTOLERANT TO INTERFERONS THERAPY | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003853-29 | Sponsor Protocol Number: METVIRAL | Start Date*: 2005-12-09 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: A randomized, controlled, multicenter clinical trial comparing the efficacy of Peginterferon alfa-2a and ribavirin and metformin versus Peginterferon alfa-2a and ribavirin for the treatment of naïv... | |||||||||||||
Medical condition: CHRONIC ACTIVE HEPATITIS C ASSOCIATED WITH INSULIN RESISTANCE | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005332-83 | Sponsor Protocol Number: PAC Peg Adefovir Combination | Start Date*: 2007-03-22 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI CASERTA | |||||||||||||
Full Title: Combined therapy with Adefovir and Interferon-Pegylated alfa 2a vs Adefovir alone, in patients affected by chronic hepatitis B, HbeAg negative (The PAC (Peg Adefovir Combination) Study). | |||||||||||||
Medical condition: Patients affected by chronic hepatitis B, HbeAg negative | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002010-37 | Sponsor Protocol Number: HBV1101 | Start Date*: 2012-02-17 | |||||||||||
Sponsor Name:Foundation for Liver research | |||||||||||||
Full Title: A Multi-center, Randomized, Open-label study for Induction of HBsAg decline using an add-on treatment of peginterferon alfa-2a in HBeAg-negative chronic hepatitis B patients treated with nucleos(t)... | |||||||||||||
Medical condition: Chronic hepatitis B virus infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000571-16 | Sponsor Protocol Number: GS-US-334-0109 | Start Date*: 2012-09-21 | ||||||||||||||||
Sponsor Name:Gilead Sciences Inc. | ||||||||||||||||||
Full Title: An Open-Label Study of GS-7977+ Ribavirin for 12 Weeks in Subjects with Chronic HCV Infection who Participated in Prior Studies Evaluating GS-7977. | ||||||||||||||||||
Medical condition: Chronic Genotype 2 or 3 HCV Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) GB (Completed) SE (Completed) EE (Completed) DE (Completed) NL (Completed) ES (Completed) PL (Completed) CZ (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-000870-63 | Sponsor Protocol Number: WV19432 | Start Date*: 2007-03-01 | |||||||||||
Sponsor Name:F.Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A phase IV, 2x2 factorial, double blind study of 24 versus 48 weeks and 90 versus 180 mcg doses of pegylated interferon alfa 2a 40KD (PEG IFN, Ro 25-8310) in adult patients with HBeAg positive chro... | |||||||||||||
Medical condition: Chronic hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-007446-54 | Sponsor Protocol Number: HBV99-03 | Start Date*: 2009-03-26 | |||||||||||
Sponsor Name:Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam | |||||||||||||
Full Title: LOWERING VIRAL LOAD WITH NUCLEOS(T)IDE ANALOGUES PRIOR TO PEG-INTERFERON ALFA-2B TREATMENT TO INCREASE SUSTAINED RESPONSE IN HBEAG-POSITIVE CHRONIC HEPATITIS B (PADD-STUDY) | |||||||||||||
Medical condition: Chronic hepatitis B virus infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001444-20 | Sponsor Protocol Number: CLDT600ACN03 | Start Date*: 2016-05-18 | |||||||||||
Sponsor Name:Beijing Novartis Pharma Co., Ltd. | |||||||||||||
Full Title: An Open-label, Single-arm, Multicenter, Phase IV, 52-week Study to Evaluate the Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients with Chronic Hepatitis B | |||||||||||||
Medical condition: chronic hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
